X-71616500-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001504.2(CXCR3):āc.972G>Cā(p.Lys324Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,209,826 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 1 hem., cov: 23)
Exomes š: 0.000030 ( 0 hom. 9 hem. )
Consequence
CXCR3
NM_001504.2 missense
NM_001504.2 missense
Scores
1
6
9
Clinical Significance
Conservation
PhyloP100: 0.710
Genes affected
CXCR3 (HGNC:4540): (C-X-C motif chemokine receptor 3) This gene encodes a G protein-coupled receptor with selectivity for three chemokines, termed CXCL9/Mig (monokine induced by interferon-g), CXCL10/IP10 (interferon-g-inducible 10 kDa protein) and CXCL11/I-TAC (interferon-inducible T cell a-chemoattractant). Binding of chemokines to this protein induces cellular responses that are involved in leukocyte traffic, most notably integrin activation, cytoskeletal changes and chemotactic migration. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One of the isoforms (CXCR3-B) shows high affinity binding to chemokine, CXCL4/PF4 (PMID:12782716). [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 9 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CXCR3 | NM_001504.2 | c.972G>C | p.Lys324Asn | missense_variant | 2/2 | ENST00000373693.4 | NP_001495.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CXCR3 | ENST00000373693.4 | c.972G>C | p.Lys324Asn | missense_variant | 2/2 | 1 | NM_001504.2 | ENSP00000362797 | P1 | |
CXCR3 | ENST00000373691.4 | c.1113G>C | p.Lys371Asn | missense_variant | 2/2 | 1 | ENSP00000362795 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112369Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34505
GnomAD3 genomes
AF:
AC:
1
AN:
112369
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34505
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 182233Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66811
GnomAD3 exomes
AF:
AC:
3
AN:
182233
Hom.:
AF XY:
AC XY:
1
AN XY:
66811
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 33AN: 1097457Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 9AN XY: 362877
GnomAD4 exome
AF:
AC:
33
AN:
1097457
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
362877
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112369Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34505
GnomAD4 genome
AF:
AC:
1
AN:
112369
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34505
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2024 | The c.1113G>C (p.K371N) alteration is located in exon 2 (coding exon 1) of the CXCR3 gene. This alteration results from a G to C substitution at nucleotide position 1113, causing the lysine (K) at amino acid position 371 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;T
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
D;T
Sift4G
Uncertain
D;D
Polyphen
D;P
Vest4
MutPred
0.47
.;Loss of methylation at K324 (P = 6e-04);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at